首页> 中文期刊> 《中国医学创新》 >系统性红斑狼疮合并肺动脉高压的临床特征及预后研究

系统性红斑狼疮合并肺动脉高压的临床特征及预后研究

         

摘要

目的:探讨系统性红斑狼疮(SLE)合并肺动脉高压(PAH)患者的临床特征以及其治疗预后。方法:选取在2008年1月-2012年4月本院风湿科收治的SLE患者64例,其中18例合并PAH患者为观察组,46例未合并PAH患者为对照组,对比两组临床特征及预后。结果:观察组心悸气促、浆膜炎、雷诺现象的发生率均明显高于对照组(P<0.05);治疗后观察组临床指标均明显优于治疗前(P<0.05),但重症SLE-PAH患者的预后较差。结论:心悸气促、浆膜炎以及雷诺现象均是SLE患者并发PAH的高危因素,对于并发PAH患者的治疗应在积极的SLE疾病治疗的基础上进行PAH的对症治疗,并尽可能的进行早期治疗,以提高治疗效果。%Objective:To investigate pulmonary hypertension in patients with systemic lupus erythematosus clinical features as well as its treatment and prognosis.Method: 64 patients with SLE were selected in our hospital from January 2008 to April 2012, 18 cases of merger PAH as observation group, 46 cases of unincorporated PAH as control group, compared two groups of clinical features and prognosis.Result:Palpitations shortness of breath, serositis, the incidence of Raynaud’s phenomenon in observation group were significantly higher than that of control group (P<0.05); After treatment the clinical indicators of observation group were significantly better than that of before treatment (P<0.05), but the prognosis of severe SLE patients with PAH was poorer. Conclusion: Heart palpitations, shortness of breath, serositis and Renault are high risk factors of the SLE patients with PAH, for the treatment of patients with concurrent PAH should be on the basis of active SLE disease treatment for symptomatic treatment of PAH, as much as possible and early treatment, in order to improve treatment effect.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号